Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services symbols : Cyth save search
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-18 (Crawled : 15:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -6.06%
H: 10.32%
C: 3.23%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: -1.16%
H: 3.51%
C: -0.58%
business year update therapeutics financial results
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results
Published: 2024-03-13 (Crawled : 21:00) - globenewswire.com
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -3.09%
H: 8.92%
C: -1.27%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: -1.2%
H: 6.06%
C: 4.24%
financial results
Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer’s Disease from the U.S. Patent and Trademark Office
Published: 2024-01-29 (Crawled : 15:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 6.43%
H: 1.58%
C: -2.75%
patent disease alzheimer’s treatment application therapeutics
Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1
Published: 2023-12-18 (Crawled : 23:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 8.03%
H: 0.54%
C: -6.76%
trappsol fda disease positive treatment meeting program therapeutics
Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024
Published: 2023-11-21 (Crawled : 19:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -0.74%
H: 0.0%
C: -8.15%
therapeutics
Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 15:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -10.88%
H: 13.74%
C: 10.69%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 3.87%
H: 0.0%
C: -4.79%
AMTI 4 | $0.263 -14.3% -1.14% 0
|
Health Technology
|
| O: -10.29%
H: 16.6%
C: 9.53%
therapeutics financial results
Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million
Published: 2023-10-23 (Crawled : 13:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 6.27%
H: 2.0%
C: 1.0%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: -2.37%
H: 3.64%
C: -10.91%
management therapeutics
Cyclo Therapeutics to Present at 8th Annual Dawson James Conference
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -3.33%
H: 1.72%
C: -0.86%
conference therapeutics
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
Published: 2023-09-21 (Crawled : 13:30) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -3.13%
H: 3.83%
C: -1.94%
AMTI 4 | $0.263 -14.3% -1.14% 0
|
Health Technology
|
| O: 32.26%
H: 0.0%
C: 0.0%
agreement molecular
Cyclo Therapeutics Reports Second Quarter 2023 Financial Results
Published: 2023-08-15 (Crawled : 14:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -4.1%
H: 1.41%
C: -4.29%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.0%
H: 0.0%
C: -3.9%
therapeutics financial results
Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.
Published: 2023-08-02 (Crawled : 13:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -2.76%
H: 5.67%
C: 5.67%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.0%
H: 2.96%
C: 2.96%
therapeutics
Cyclo Therapeutics Announces Publication of Positive Data from Phase 2 Clinical Study of Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1
Published: 2023-06-29 (Crawled : 22:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 1.72%
H: 9.6%
C: -11.3%
trappsol disease positive publication treatment therapeutics study
Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
Published: 2023-06-13 (Crawled : 20:00) - globenewswire.com
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: -3.48%
H: 9.0%
C: -5.41%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 1.82%
H: 0.0%
C: -4.02%
business update financial results
Cyclo Therapeutics Announces Allowance of Patent from European Patent Office for Trappsol® Cyclo™ for Alzheimer’s Disease
Published: 2023-06-12 (Crawled : 15:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 5.62%
H: 27.38%
C: 14.79%
trappsol patent disease alzheimer’s therapeutics
Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement
Published: 2023-06-05 (Crawled : 13:20) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 4.29%
H: 14.38%
C: 8.9%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.0%
H: 1.76%
C: 1.32%
therapeutics funding agreement
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results
Published: 2023-05-15 (Crawled : 13:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 2.48%
H: 0.0%
C: -14.51%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.73%
H: 0.0%
C: -2.29%
business update therapeutics financial results
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)
Published: 2023-05-02 (Crawled : 13:20) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 3.36%
H: 18.7%
C: 12.2%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: -1.49%
H: 4.02%
C: -0.5%
therapeutics
Cyclo Therapeutics Announces Closing of $1.3 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Published: 2023-04-21 (Crawled : 13:20) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 8.78%
H: 0.0%
C: -1.15%
nasdaq therapeutics
Cyclo Therapeutics Provides Clinical Program Update and Highlights Recent Achievements
Published: 2023-01-11 (Crawled : 14:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 1.05%
H: 7.25%
C: -2.07%
program therapeutics update
Cyclo Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event
Published: 2023-01-10 (Crawled : 14:20) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 0.55%
H: 11.48%
C: 4.37%
companies therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.